Among them, IRF9 and XRCC1 attracted our attention and were identified as the potential gene biomarkers for PsP and TTP, based on the results from the functional annotation, pathway enrichment analysis, and published data. The gene discussed is IRF9; the disease is supranuclear palsy, progressive, 1.